UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma

Hepatology international, 2024-06, Vol.18 (3), p.973-983

2024

Volltextzugriff (PDF)

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study

Gastrointestinal endoscopy, 2010-07, Vol.72 (1), p.25-32

2010

Volltextzugriff (PDF)

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Cancer, 2008-06, Vol.112 (11), p.2368-2376

2008

Volltextzugriff (PDF)

Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors

Investigational new drugs, 2014-04, Vol.32 (2), p.340-346

2014

Volltextzugriff (PDF)

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Journal of cancer education, 2020-06, Vol.35 (3), p.545-556

2020

Volltextzugriff (PDF)

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Cancer science, 2010-03, Vol.101 (3), p.793-799

2010

Volltextzugriff (PDF)

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer

BMC cancer, 2021-04, Vol.21 (1), p.413-9, Article 413

2021

Volltextzugriff (PDF)

Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients: A Viewpoint in the Era of Preoperative Treatment

Annals of surgery, 2010-03, Vol.251 (3), p.428-435

2010

Volltextzugriff (PDF)

Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-11, Vol.20 (6), p.970-977

2017

Volltextzugriff (PDF)

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-04, Vol.19 (2), p.586-596

2016

Volltextzugriff (PDF)

A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas

Cancer chemotherapy and pharmacology, 2013-04, Vol.71 (4), p.981-990

2013

Volltextzugriff (PDF)

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Vol.20 (1), p.146-155

2017

Volltextzugriff (PDF)

Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience

Cancer chemotherapy and pharmacology, 2014-11, Vol.74 (5), p.995-1003

2014

Volltextzugriff (PDF)

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-09, Vol.21 (5), p.802-810

2018

Volltextzugriff (PDF)

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Vol.20 (1), p.182-189

2017

Volltextzugriff (PDF)

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

Cancer chemotherapy and pharmacology, 2011, Vol.67 (1), p.127-136

2011

Volltextzugriff (PDF)

Gastric cancer patients at high-risk of having synchronous cancer

World journal of gastroenterology : WJG, 2006-04, Vol.12 (16), p.2588

2006

Volltextzugriff (PDF)

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation

Cancer chemotherapy and pharmacology, 2013, Vol.71 (1), p.43-51

2013

Volltextzugriff (PDF)

Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer

Surgical endoscopy, 2011-05, Vol.25 (5), p.1505-1513

2011

Volltextzugriff (PDF)

Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer

Journal of gastroenterology, 2006-04, Vol.41 (4), p.339-346

2006

Volltextzugriff (PDF)

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients

Cancer chemotherapy and pharmacology, 2010-02, Vol.65 (3), p.579-587

2010

Volltextzugriff (PDF)

Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer

Hepato-gastroenterology, 2012-03, Vol.59 (114), p.430

2012

Volltextzugriff (PDF)

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

Annals of surgical oncology, 2010-12, Vol.17 (12), p.3163-3172

2010

Volltextzugriff (PDF)

Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: Results of prospective single center trials

Journal of surgical oncology, 2009-03, Vol.99 (3), p.137-142

2009

Volltextzugriff (PDF)

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer

Pharmacogenomics, 2009-07, Vol.10 (7), p.1147-1155

2009

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaAdult

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Female
(63)
Humans
(63)
Male
(63)
Middle Aged
(63)
Science & Technology
(60)
Life Sciences & Biomedicine
(59)
Oncology
(39)
Stomach Neoplasms - Pathology
(30)
Gastric Cancer
(27)
Stomach Neoplasms - Drug Therapy
(26)
Medicine
(25)
Aged, 80 And Over
(22)
Medicine & Public Health
(22)
Tumors
(20)
Treatment Outcome
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Retrospective Studies
(18)
Surgery
(18)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer

Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients: A Viewpoint in the Era of Preoperative Treatment

Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival

A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer

Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement

Gastric cancer patients at high-risk of having synchronous cancer

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation

Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer

Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients

Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer

Clinical Outcomes and Prognostic Factors of Metastatic Gastric Carcinoma Patients Who Experience Gastrointestinal Perforation During Palliative Chemotherapy

Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: Results of prospective single center trials

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer

Aktive Filter

Suchergebnisse filtern